What is SUSVIMO®?
SUSVIMO is a prescription medicine used to treat adults with neovascular (wet) Age‐related Macular Degeneration (AMD) who have responded to at least two injections of a Vascular Endothelial Growth Factor (VEGF) inhibitor in the gel-like part of the eye (intravitreal).
Learning About wet AMD
Wet age-related macular degeneration (wet AMD) is an eye condition that can impact how clearly you see. This can make everyday life difficult and challenging. Learning about what’s happening in your eye can help you better understand how treatment works.
How wet AMD affects the eye
A protein called VEGF is known to be a primary driver of the disease causing the underlying issues in the eye:
Blood vessels grow abnormally in the eye → The blood vessels leak fluid into a part of the eye called the macula → The macula swells, leading to blurred vision and vision loss
How wet AMD affects your life
Traditional treatments for wet AMD involve anti-VEGF injections into the eye, which are designed to block VEGF proteins, improving and maintaining vision. However, these injections usually need to be given on a regular basis. Frequent visits to your retina specialist may take away from your free time and eye injections can be a daunting experience for some people with wet AMD.
Continuous Delivery of wet AMD Treatment with SUSVIMO®
SUSVIMO is an implant placed in your eye during a one-time surgical procedure.
Over the next 6 months, SUSVIMO slowly releases medicine into your eye, continuously delivering treatment.
The medicine inside the implant is called ranibizumab. It has been trusted by Retina Specialists for years to treat wet AMD.
Dr. Mehran Taban and his team were the first in Los Angeles county to preform the SUSVIMO implant procedure since relaunch in 2024.
To learn more about SUSVIMO, click here.